Succinic Acid → HCID 86619558, compound

HRID 1869594Notes

Reaction equation

[O:1]=[C:2]1[N:8]([CH:9]2[CH2:14][CH2:13][N:12]([C:15]([O:17][C@H:18]([CH2:34][C:35]3[CH:40]=[C:39]([C:41]([F:44])([F:43])[F:42])[C:38]([NH2:45])=[C:37]([Cl:46])[CH:36]=3)[C:19]([N:21]3[CH2:26][CH2:25][CH:24]([N:27]4[CH2:32][CH2:31][N:30]([CH3:33])[CH2:29][CH2:28]4)[CH2:23][CH2:22]3)=[O:20])=[O:16])[CH2:11][CH2:10]2)[CH2:7][CH2:6][C:5]2[CH:47]=[CH:48][CH:49]=[CH:50][C:4]=2[NH:3]1.[C:51]([OH:58])(=[O:57])[CH2:52][CH2:53][C:54]([OH:56])=[O:55]>C(O)(C)C>[C:51]([OH:58])(=[O:57])[CH2:52][CH2:53][C:54]([OH:56])=[O:55].[C:51]([OH:58])(=[O:57])[CH2:52][CH2:53][C:54]([OH:56])=[O:55].[O:1]=[C:2]1[N:8]([CH:9]2[CH2:14][CH2:13][N:12]([C:15]([O:17][C@H:18]([CH2:34][C:35]3[CH:40]=[C:39]([C:41]([F:43])([F:42])[F:44])[C:38]([NH2:45])=[C:37]([Cl:46])[CH:36]=3)[C:19]([N:21]3[CH2:26][CH2:25][CH:24]([N:27]4[CH2:28][CH2:29][N:30]([CH3:33])[CH2:31][CH2:32]4)[CH2:23][CH2:22]3)=[O:20])=[O:16])[CH2:11][CH2:10]2)[CH2:7][CH2:6][C:5]2[CH:47]=[CH:48][CH:49]=[CH:50][C:4]=2[NH:3]1

Participants

Conditions

Temperature: 50 °C

Procedure

0.5 g (0.69 mmol) (R)-1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate are dissolved in 5 ml isopropanol at ambient temperature, combined with 82 mg (0.69 mmol) succinic acid and heated to 50° C. After 18 hours at 50° C. a white precipitate has formed. The suspension is cooled to 30° C., filtered, washed with isopropanol and dried.

Workup

customAfter 18 hours at 50° C. a white precipitate has formed
temperatureThe suspension is cooled to 30° C.
filtrationfiltered
washwashed with isopropanol
customdried

Sources & evidence

ORD record: ord-12a29b31c06944989cfe2ce47fb67cee
Source dataset: uspto-grants-2009_12
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07638625B2

Reaction notes

Loading…